EP Patent

EP2637650A2 — Methods to test allergic conditions

Assigned to National Jewish Health · Expires 2013-09-18 · 13y expired

What this patent protects

Disclosed are methods to treat allergic conditions, including pulmonary and non- pulmonary conditions, in a subject by administering a composition that inhibits Pirn kinase. Also disclosed are methods to treat allergic conditions in a subject by administering a composition that i…

USPTO Abstract

Disclosed are methods to treat allergic conditions, including pulmonary and non- pulmonary conditions, in a subject by administering a composition that inhibits Pirn kinase. Also disclosed are methods to treat allergic conditions in a subject by administering a composition that induces expression of Runx3.

Drugs covered by this patent

Patent Metadata

Patent number
EP2637650A2
Jurisdiction
EP
Classification
—
Expires
2013-09-18
Drug substance claim
No
Drug product claim
No
Assignee
National Jewish Health
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.